Announcements Trials

Browse Landscape

Phase

Phase 2 1 Phase 1/2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neuroendocrine Tumors 5 Gastro-enteropancreatic neuroendocrine tumor 2 Adenoma, Islet Cell 2 Pancreatic Neoplasms 1 Neuroblastoma 1 Glioblastoma 1

Interventions

Cyclophosphamide 32 Filgrastim 18 Irinotecan 15 Topotecan 14 Temozolomide 13 Vincristine 12 Peripheral Blood Stem Cell Transplantation 12 Granulocyte Colony-Stimulating Factor 12 Etoposide 12 Melphalan 11 fludarabine 10 Carboplatin 9 dinutuximab 8 Isotretinoin 8 Interleukin-2 8 Busulfan 8 humanized 3F8 anti-GD2 monoclonal antibody 7 aldesleukin 7 Doxorubicin 7 3-Iodobenzylguanidine 7 sargramostim 6 fludarabine phosphate 6 Vorinostat 6 Zoledronic Acid 5 Stem Cell Transplantation 5 Cisplatin 5 etoposide phosphate 4 Ipilimumab 4 Drug Therapy 4 ribociclib 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Neuroblastoma × lutetium Lu 177 dotatate × Clear all

NCT03966651 2026-04-29

NEUROBLU 02

Institut Claudius Regaud

Phase 1 Completed

Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡